Impact of COVID-19 on cancer patients: A review #MMPMID32970923
Cavalcanti IDL; Soares JCS
Asia Pac J Clin Oncol 2021[Jun]; 17 (3): 186-192 PMID32970923show ga
To inform about the impact of COVID-19 on cancer patients, a literature review was carried out, using the descriptors "COVID-19," "SARS-CoV-2," "Oncology," and "Coronavirus," in the Pubmed, Sciencedirect, and Scifinder databases. Fifty-three articles were included after analyzing the inclusion and exclusion criteria, being divided into five sessions: Epidemiological aspects of COVID-19; Pathophysiology of COVID-19; Clinical aspects of cancer patients; Risks to cancer patients infected with COVID-19; and Care for cancer patients amid a pandemic. The cancer patient has a weakened immune system, due to characteristics specific to the development of cancer or even chemotherapy, leaving these patients more susceptible to infections by COVID-19. Thus, the development of protection plans for cancer patients should be encouraged, reducing the exposure of these patients to the SARS-CoV-2 virus, contributing to the maintenance of the health of the cancer patient, and avoiding possible therapeutic complications that can lead the patient to death.
Asia+Pac+J+Clin+Oncol 2021 ; 17 (3): 186-192
